
Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company advancing T cell engaging ("TCE") bispecific antibodies for solid tumors. Context is building an innovative portfolio of TCE bispecific therapeutics with multiple products in development, including two clinical-stage assets. Con... Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company advancing T cell engaging ("TCE") bispecific antibodies for solid tumors. Context is building an innovative portfolio of TCE bispecific therapeutics with multiple products in development, including two clinical-stage assets. Context is headquartered in Philadelphia. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.2035 | -24.2637415047 | 0.8387 | 0.8387 | 0.6 | 696977 | 0.65559135 | CS |
4 | -0.0848 | -11.7777777778 | 0.72 | 0.8387 | 0.49 | 395438 | 0.63066278 | CS |
12 | -0.1366 | -17.6988857217 | 0.7718 | 1.04 | 0.49 | 246760 | 0.68849305 | CS |
26 | -0.7548 | -54.3021582734 | 1.39 | 1.39 | 0.49 | 344189 | 0.88669962 | CS |
52 | -1.3348 | -67.7563451777 | 1.97 | 2.75 | 0.49 | 303223 | 1.38284561 | CS |
156 | -1.4348 | -69.3140096618 | 2.07 | 2.75 | 0.47 | 385304 | 1.26972964 | CS |
260 | -3.8048 | -85.6936936937 | 4.44 | 10.87 | 0.47 | 688552 | 3.51528401 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.